Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Enhancer Transcription Reveals Subtype-Specific Transcription Programs Controlling Breast Cancer Pathogenesis

ABSTRACT: Enhancer Transcription Reveals Subtype-Specific Transcription Programs Controlling Breast Cancer Pathogenesis

PROVIDER: PRJNA379949 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5364060.fastq.gz	Fastqsanger.gz
	SRR5364070.fastq.gz	Fastqsanger.gz
	SRR5364080.fastq.gz	Fastqsanger.gz
	SRR5364090.fastq.gz	Fastqsanger.gz
	SRR5364100.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 102

Similar Datasets

Enhancer Transcription Reveals Subtype-Specific Transcription Programs Controlling Breast Cancer Pathogenesis [RNA-Seq]

2017-11-22 | GSE96860 | GEO

Enhancer Transcription Reveals Subtype-Specific Transcription Programs Controlling Breast Cancer Pathogenesis [GRO-Seq]

2017-11-22 | GSE96859 | GEO

Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.

Project description:Noncoding transcription is a defining feature of active enhancers, linking transcription factor (TF) binding to the molecular mechanisms controlling gene expression. To determine the relationship between enhancer activity and biological outcomes in breast cancers, we profiled the transcriptomes (using GRO-seq and RNA-seq) and epigenomes (using ChIP-seq) of 11 different human breast cancer cell lines representing five major molecular subtypes of breast cancer, as well as two immortalized ("normal") human breast cell lines. In addition, we developed a robust and unbiased computational pipeline that simultaneously identifies putative subtype-specific enhancers and their cognate TFs by integrating the magnitude of enhancer transcription, TF mRNA expression levels, TF motif P-values, and enrichment of H3K4me1 and H3K27ac. When applied across the 13 different cell lines noted above, the Total Functional Score of Enhancer Elements (TFSEE) identified key breast cancer subtype-specific TFs that act at transcribed enhancers to dictate gene expression patterns determining growth outcomes, including Forkhead TFs, FOSL1, and PLAG1. FOSL1, a Fos family TF, (1) is highly enriched at the enhancers of triple negative breast cancer (TNBC) cells, (2) acts as a key regulator of the proliferation and viability of TNBC cells, but not Luminal A cells, and (3) is associated with a poor prognosis in TNBC breast cancer patients. Taken together, our results validate our enhancer identification pipeline and reveal that enhancers transcribed in breast cancer cells direct critical gene regulatory networks that promote pathogenesis.

| S-EPMC5793780 | biostudies-literature

Core Transcription Programs Controlling Injury-Induced Neurodegeneration of Retinal Ganglion Cells

Project description:Core Transcription Programs Controlling Injury-Induced Neurodegeneration of Retinal Ganglion Cells

| PRJNA787937 | ENA

Enhancer Transcription Reveals Subtype-Specific Transcription Programs Controlling Breast Cancer Pathogenesis

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-11-22 | GSE96867 | GEO

Homo sapiens

Project description:Enhancer Transcription Reveals Subtype-Specific Transcription Programs Controlling Breast Cancer Pathogenesis [RNA-Seq]

| PRJNA379957 | ENA

Homo sapiens

Project description:Enhancer Transcription Reveals Subtype-Specific Transcription Programs Controlling Breast Cancer Pathogenesis [GRO-Seq]